The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,373,839 in first-year total cost, median $2,186,920.
Most frequent study sections
- Imaging Probes and Contrast Agents Study Section[IPCA]1
- Special Emphasis Panel[ZRG1 IMST-Q (02)]1
Most frequent institutions
- SLOAN-KETTERING INST CAN RESEARCH1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | [18F]-PU-AD epichaperome PET imaging probe1RF1AG071805-01A1 | CHIOSIS, GABRIELADUNPHY, MARK P.PILLARSETTY, NAGAVARAKISHORE | SLOAN-KETTERING INST CAN RESEARCH, NY | $3,589,781 | IPCA |
| 2022 | First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain1R01AG072743-01A1 | GERDES, JOHN MVANBROCKLIN, HENRY F.WILSON, DAVID M | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $784,058 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.